ADAP plays a pivotal role in CD4+ T cell activation but is only marginally involved in CD8+ T cell activation, differentiation, and immunity to pathogens
ADAP plays a pivotal role in CD4+ T cell activation but is only marginally involved in CD8+ T cell activation, differentiation, and immunity to pathogens
复制标题
DOI:
10.1189/jlb.1a0216-090rr
复制
发表时间:
2017-02
影响因子:
5.5
通讯作者:
G. Parzmair;M. Gereke;Oxana Haberkorn;M. Annemann;Lisa Podlasly;S. Kliche;A. Reinhold;B. Schraven;D. Bruder
中科院分区:
文献类型:
--
作者:
G. Parzmair;M. Gereke;Oxana Haberkorn;M. Annemann;Lisa Podlasly;S. Kliche;A. Reinhold;B. Schraven;D. Bruder
The adhesion and degranulation promoting adaptor protein (ADAP) is a multifunctional scaffold involved in many different signaling pathways that are important for the function of T cells, including the inside‐out and outside‐in signaling of integrins, the activation of NF‐κB, and the subsequent production of proinflammatory cytokines (e.g., IFN‐γ and IL‐2). Strikingly, despite its well‐established role in T cells, previous studies did not distinguish between CD4+ and CD8+ T cells, and thus, it is unknown whether ADAP fulfills equally important functions in both T cell subsets. We show here that despite comparable ADAP expression levels in CD4+ and CD8+ T cells, their function is differentially dependent on ADAP. Whereas in vitro TCR‐stimulation experiments revealed that activation, proliferation, and adhesion are severely compromised in CD4+ T cells lacking ADAP, their CD8+ counterparts are hardly affected by ADAP deficiency. Accordingly, antigen‐specific in vivo stimulation of adoptively transferred CD8+ T cells during Listeria monocytogenes (Lm) and influenza A virus (IAV) infection revealed only moderate effects of ADAP deficiency in terms of CD8+ T cell activation, proliferation, and differentiation, which, however, did not impair pathogen‐specific immunity. Thus, we show for the first time that ADAP fulfills different functions in CD4+ and CD8+ T cells, with CD8+ T cells being less dependent on ADAP. Our data identify ADAP as a potential molecular target for T cell subset‐specific therapeutic interventions.